Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Idram and IDBank Participated in the Opening of My Forest Armenia’s Pavilion at COP17Unibank Receives B++ Sustainability Alignment Rating from Agents for Impact GmbH Ucom Supported Yerevan Conservation Symposium 2026 as Strategic PartnerIDBank to Showcase Environmental and Innovative Initiatives at COP17New AI-Powered Wildlife Monitoring Camera Installed in Paruyr Sevak with the Support of Ucom35 Years of Trust: IDBank Celebrates with Its CustomersBusiness and mining leader Mark Cutifani to deliver keynote speech at the 3rd Mining Armenia Forum“From Classroom to Orbit”: With Ucom’s Support, “Space 1.0” Is Being Introduced in 15 Schools Across ArmeniaAfeyan Initiatives for Armenia Awards Grant to the Armenia Education Initiative to Expand the Teach For Armenia’s Seroond School Turnaround Program Ucom to Participate in COP17 Together with FPWC, Showcasing Their Environmental Partnership“The Golden Hour”: IDBank explains how to respond effectively to a scam attackNelli Kocharyan Presents Converse Bank’s Vision for Development of International Relations at the BACEE Conference BACEE International Conference Kicks Off with Converse Bank as Lead Sponsor Unibank has issued perpetual bonds with an annual coupon yield of 13.2% Ucom Measures the Environmental Impact of Its OperationsUnibank Offers USD-Denominated Bonds with an Annual Coupon Rate of 6% Ucom Becomes an Official Partner of the Armenia-UK Business Forum 2026Ucom Sales and Service Center at 20/52 Erebuni Reopens After Renovation Unibank Joins the Armenian Solar Energy AssociationThe Widely Discussed Dvin Crown Project. A New Visibility Platform for Brands Has Emerged in the Heart of Yerevan
Life

Paracetamol claimed to be ineffective against most types of pain, study claims

Paracetamol is one of the most popular drugs that people take to combat pain or fever, but it is claimed to be ineffective against most types of pain.

Scientists at Sydney's University analyzed systematic reviews of 3,570 studies that looked at the efficacy and safety of paracetamol for treating 44 types of pain conditions. Meanwhile, a single or multiple intake of a standard dose of a popular drug (0.5-1 g) is superior to placebo only for 4 painful conditions - osteoarthritis of the knee and hip joints, recovery from the craniotomy, pelvic pain, including postpartum pain, and headache voltage.

For common conditions such as migraines and headaches with colds, as well as low back pain, the evidence for the effectiveness of paracetamol was too low or inconclusive.

Scientists questioned the recommendation of taking paracetamol for pain in the lumbosacral region back in 2016 when a randomized placebo-controlled trial involving 1,652 patients found no difference between the popular pain reliever and placebo.